It’s been a busy start to the Fall season in my world of startups. A new class has just started at IndieBio. UCSF Catalyst recently finished a round of progress updates for its awardees and is already looking at the next round of proposals. UC [...]
Eighteen months of darkness When an applicant files an application for a patent, the first publication generally is 18 months from that first filing date. The first date may be the filing date of the provisional application in the US or the priority [...]
When I look back on my PhD thesis, the time is memorable. What holds no memories however, is actually crossing the finish line. When I completed the draft of my thesis, I left for my post-doctoral position. There was no ceremony, no fanfare, nothing to [...]
Patent claims are where it’s at if you are looking at freedom to operate. Keep in mind, however, that it’s really issued claims that are the worry. I get a fair bit of concerns sent my way about patent applications. It comes in two flavors. [...]
The regulations governing obligations related to patent filings changed in 2018. But now, almost a year later, I find that very few grant recipients are aware of the recently added obligations or even more generally, of the ones that remain the same. In a [...]
Appreciate choice – that is what my mediation app advised. At the time, I gave it only a passing thought. Yes, it is nice to have choices and not be stuck down a single path. However, do we really appreciate choice? Do we consciously [...]
When I was growing up there was a rumor that went around school: a fast food restaurant had somehow deep fried a rat instead of a chicken piece and served it to a customer. I have my doubts on the veracity of that one, but [...]
So many biotech start-ups, and so many different ways to navigate from point A to point B. I attended two talks recently which provided a contrast in styles for designing and getting a startup off the ground. Both paths were successful, but success came [...]
Sitting in a room several weeks ago, I found myself looking at an unusual sight. In front of me was a panel of 6 women, all very accomplished experienced professionals in the biotech arena – CEOs, board members and investors. Why was this unusual? [...]
Another JPM week rolls around and in comes the rainy weather to SF. It’s getting to be quite a pattern. Each year I look forward to it and dread it. It’s a week of seeing colleagues, meeting lots of new people, and learning about [...]
